Select Medical Holdings Corp
NYSE:SEM

Watchlist Manager
Select Medical Holdings Corp Logo
Select Medical Holdings Corp
NYSE:SEM
Watchlist
Price: 17.58 USD 6.03% Market Closed
Market Cap: 2.3B USD

Select Medical Holdings Corp
Investor Relations

Select Medical Holdings Corp. operates in a nuanced and complex healthcare environment, transforming the landscape of rehabilitation and critical illness recovery. Founded in 1996, the company embarked on its journey with a vision to bridge gaps in post-acute care, establishing a network that today includes long-term acute care hospitals, inpatient rehabilitation facilities, and outpatient clinics. This vast network caters to individuals requiring extended medical care, rehabilitation, or therapy following serious illnesses or injuries. The company's operational model revolves around specialized healthcare services, offering a continuum of care that supports patient recovery from severe health conditions to regaining independence.

At the heart of Select Medical's business strategy is its ability to monetize diversified segments within healthcare. The company generates revenue through its hospital and outpatient divisions. Long-term acute care hospitals serve patients with critical, acute, and chronic illnesses over extended periods, while inpatient rehabilitation facilities provide intensive therapy and rehabilitation programs. Furthermore, their outpatient rehabilitation clinics offer physical, occupational, and speech therapy to a broader demographic. This multi-faceted approach not only addresses various healthcare needs but also stabilizes revenue streams by reducing dependency on any single segment. By creating a synergy between its service lines, Select Medical positions itself as a comprehensive service provider, maximizing its capability to benefit from the intricate dynamics of the healthcare sector.

Show more
Loading

Earnings Calls

2024 Q4
Feb 5, 2025
Show Transcript
Previous
Next
Vishay Reports Slight Revenue Decline, Positive Trends Ahead
2024 Q4
Feb 5, 2025

In the fourth quarter, Vishay's revenue reached $714.7 million, a slight dip from Q3, contributing to a full-year total of $2.9 billion, reflecting sector-wide inventory adjustments and weaker European demand. Encouragingly, the company noted a book-to-bill ratio of 1.01, indicating enhanced order intake, with particular strength in semiconductor demand related to AI and smart grid projects. For Q1 2025, revenue guidance is set at $710 million plus or minus $20 million, with expected gross margins around 19%. Depreciation is projected at $53 million, maintaining dividends despite anticipated negative free cash flow due to ongoing capacity expansions.

Show Full Analysis

Management

Mr. Robert A. Ortenzio
Co-Founder & Executive Chairman
No Bio Available
Mr. David S. Chernow
Chief Executive Officer
No Bio Available
Mr. Michael F. Malatesta
Executive VP & CFO
No Bio Available
Mr. Michael E. Tarvin
Senior Executive VP, General Counsel & Secretary
No Bio Available
Mr. Martin F. Jackson
Senior Executive Vice President of Strategic Finance & Operations
No Bio Available
Mr. Thomas P. Mullin
Co-President
No Bio Available
Mr. Christopher S. Weigl
Senior VP, Controller & Chief Accounting Officer
No Bio Available
Mr. Brian R. Rusignuolo
Executive VP & Chief Information Officer
No Bio Available
Mr. Robert G. Breighner Jr.
Senior Vice President of Compliance & Audit
No Bio Available

Contacts

Address
PENNSYLVANIA
Mechanicsburg
4714 Gettysburg Rd
Contacts